共 50 条
- [1] CLINICAL PHARMACOLOGY OF HIGH-DOSE METHOTREXATE (NSC-740) CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 25 - 29
- [2] INTRODUCTION - PERSPECTIVES ON HIGH-DOSE METHOTREXATE (NSC-740) THERAPY CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 1 - 2
- [3] HIGH-DOSE METHOTREXATE (NSC-740) AND CITROVORUM FACTOR (NSC-3590) RESCUE - BACKGROUND AND RATIONALE CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 3 - 6
- [4] TOXICITY OF HIGH-DOSE METHOTREXATE (NSC-740) AND CITROVORUM FACTOR (NSC-3590) IN OSTEOGENIC SARCOMA CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 31 - 36
- [5] KINETIC-MODEL FOR DISPOSITION AND METABOLISM OF MODERATE AND HIGH-DOSE METHOTREXATE (NSC-740) IN MAN CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 811 - 817
- [6] CLINICAL TRIAL OF HIGH-DOSE METHOTREXATE (NSC-740) WITH CITROVORUM FACTOR (NSC-3590)-TOXICOLOGIC AND THERAPEUTIC OBSERVATIONS CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 43 - 49
- [7] OVERVIEW OF PROTOCOLS ON CLINICAL STUDIES OF HIGH-DOSE METHOTREXATE (NSC-740) WITH CITROVORUM FACTOR (NSC-3590) RESCUE CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 7 - 12
- [8] PROGRESS REPORT ON HIGH-DOSE METHOTREXATE (NSC-740) WITH CITROVORUM RESCUE IN TREATMENT OF METASTATIC BONE TUMORS CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (02): : 275 - 280
- [9] RESPONSE, TOXICITY, AND PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE (NSC-740) WITH CITROVORUM FACTOR (NSC-3590) RESCUE FOR CHILDREN WITH OSTEOSARCOMA AND OTHER MALIGNANT-TUMORS CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 13 - 18
- [10] LOW DOSAGE METHOTREXATE (NSC-740) AND CYCLOPHOSPHAMIDE (NSC 26271) FOR SOLID TUMORS CANCER CHEMOTHERAPY REPORTS PART 1, 1970, 54 (01): : 41 - &